Professional Documents
Culture Documents
Full Download Book Neurology Neonatology Questions and Controversies Neonatology Questions Controversies PDF
Full Download Book Neurology Neonatology Questions and Controversies Neonatology Questions Controversies PDF
Full Download Book Neurology Neonatology Questions and Controversies Neonatology Questions Controversies PDF
Neonatology
Questions and
Controversies
Series Editor
Richard A. Polin, MD
William T. Speck Professor of Pediatrics
College of Physicians and Surgeons
Columbia University;
Director Division of Neonatology
New York Presbyterian
Morgan Stanley Children’s Hospital
New York, New York
Neonatology
Questions and
Controversies
Third Edition
Consulting Editor
Richard A. Polin, MD
William T. Speck Professor of Pediatrics
College of Physicians and Surgeons
Columbia University;
Director Division of Neonatology
New York Presbyterian
Morgan Stanley Children’s Hospital
New York, New York
1600 John F. Kennedy Blvd.
Ste 1800
Philadelphia, PA 19103-2899
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or me-
chanical, including photocopying, recording, or any information storage and retrieval system, without permis-
sion in writing from the publisher. Details on how to seek permission, further information about the Publisher’s
permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the
Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher (other
than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience broaden
our understanding, changes in research methods, professional practices, or medical treatment may become
necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and
using any information, methods, compounds, or experiments described herein. In using such information or
methods they should be mindful of their own safety and the safety of others, including parties for whom they
have a professional responsibility.
With respect to any drug or pharmaceutical products identified, readers are advised to check the most
current information provided (i) on procedures featured or (ii) by the manufacturer of each product to be
administered, to verify the recommended dose or formula, the method and duration of administration, and
contraindications. It is the responsibility of practitioners, relying on their own experience and knowledge of
their patients, to make diagnoses, to determine dosages and the best treatment for each individual patient, and
to take all appropriate safety precautions.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume
any liability for any injury and/or damage to persons or property as a matter of products liability, negligence
or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the
material herein.
Names: Perlman, Jeffrey M., editor. | Cilio, Maria Roberta, editor. | Polin,
Richard A. (Richard Alan), 1945- editor.
Title: Neurology: neonatology questions and controversies / [edited by]
Jeffrey M. Perlman, Maria Roberta Cilio; consulting editor, Richard A.
Polin.
Other titles: Neurology (Perlman) | Neonatology questions and controversies.
Description: Third edition. | Philadelphia, PA: Elsevier, [2019] | Series:
Neonatology questions and controversies | Includes bibliographical
references and index.
Identifiers: LCCN 2018011667 | ISBN 9780323543927 (hardcover: alk. paper)
Subjects: | MESH: Nervous System Diseases | Infant, Newborn, Diseases
| Infant, Newborn
Classification: LCC RJ290 | NLM WS 340 | DDC 618.92/8--dc23 LC record
available at https://lccn.loc.gov/2018011667
Printed in China
v
vi Contributors
ix
Series Foreword
Richard A. Polin, MD
“To study the phenomena of disease without books is to sail an uncharted sea, while to
study books without patients is not to go to sea at all.”
—William Osler
Physicians in training generally rely on the spoken word and clinical experi-
ences to bolster their medical knowledge. There is probably no better way to learn
how to care for an infant than to receive teaching at the bedside. Of course, that
assumes that the “clinician” doing the teaching is knowledgeable about the disease,
wants to teach, and can teach effectively. For a student or intern, this style of learning
is efficient because the clinical service demands preclude much time for other read-
ing. Over the course of one’s career, it becomes clear that this form of education has
limitations because of the fairly limited number of disease conditions one encounters
even in a lifetime of clinical rotations and the diminishing opportunities for teaching
moments.
The next educational phase generally includes reading textbooks and qualita-
tive review articles. Unfortunately, both of those sources are often outdated by the
time they are published and represent one author’s opinions about management.
Systematic analyses (meta-analyses) can be more informative, but more often than
not the conclusion of the systematic analysis is that “more studies are needed” to
answer the clinical question. Furthermore, it has been estimated that if a subsequent
large randomized clinical trial had not been performed, the meta-analysis would have
reached an erroneous conclusion more than one-third of the time.
For practicing clinicians, clearly the best way to keep abreast of recent advances
in a field is to read the medical literature on a regular basis. However, that approach
is problematic given the multitude of journals, unless one reads only the two or three
major pediatric journals published in the United States. That approach however, will
miss many of the outstanding articles that appear in more general medical journals
(e.g., Journal of the American Medical Association, New England Journal of Medicine,
Lancet, and the British Medical Journal), subspecialty journals, and the many pediatric
journals published in other countries.
Whereas there is no substitute to reading journal articles on a regular basis,
the “Questions and Controversies” series of books provides an excellent alternative.
This third edition of the series was developed to highlight the clinical problems of
most concern to practitioners. The series has been increased from six to seven vol-
umes and includes new sections on genetics and pharmacology. In total, there are 70
new chapters not included previously. The editors of each volume (Drs. Bancalari,
Davis, Keszler, Oh, Baum, Seri, Ohls, Christensen, Maheshwari, Neu, Benitz, Smith,
Poindexter, Cilio, and Perlman) have done an extraordinary job in selecting topics
of clinical importance to everyday practice. Unlike traditional review articles, the
chapters not only highlight the most significant controversies, but when possible,
have incorporated basic science and physiological concepts with a rigorous analysis
of the current literature.
As with the first edition, I am indebted to the exceptional group of editors
who chose the content and edited each of the volumes. I also wish to thank Lisa
Barnes (Content Development Specialist at Elsevier) and Judy Fletcher (VP, Content
Development at Elsevier) who provided incredible assistance in bringing this project
to fruition.
xi
CHAPTER 1
Cerebral Circulation and
Hypotension in the Premature
Infant: Diagnosis and Treatment
Shahab Noori, Claire McLean, Tai Wei-Wu, and Istvan Seri
With the evolution of neonatology over the past few decades, improved methods of
monitoring an more effective interventions have been developed to identify and
manage the respiratory, fluid and electrolyte, and nutritional abnormalities frequently
enG urntered in very low-birth-weight (VLBW) infants. However, the ability to effec-
tively and continuously monitor the hemodynamic changes at the level of systemic
and organ blood flow and tissue perfusion is still limited. Yet the advances achieved
with the use of targeted neonatal echocardiography and other bedside monitoring
devices providing noninvasive, continuous systemic, organ and tissue perfusion and
cerebral function monitoring have started to usher in a new era in developmental
hemodynamics. The novel monitoring modalities include but are not restricted to
electrical impedance velocimetry, continuous wave Doppler ultrasonography, near-
infrared spectroscopy (NIRS), visible light spectroscopy, laser Doppler technol-
ogy, and amplitude-integrated electroencephalography (EEG, aEEG). Yet with the
improvements in hemodynamic monitoring and a better understanding of the prin-
ciples of developmental cardiovascular physiology have come the realization that
little is known about circulatory compromise and its effects on organ function, espe-
cially brain blood flow, blood flow-metabolism coupling, and long-term outcomes.
Although we can continuously and reliably monitor systemic blood pressure in abso-
lute numbers and a great number of proposed interventions exist for "normalizing"
it, blood pressure is only the dependent component among the three hemodynamic
parameters regulating systemic perfusion. Accordingly, blood pressure is determined
2 Neurology
by changes in the two independent variables, cardiac output and systemic vascu-
lar resistance (SVR). Therefore in addition to monitoring and maintaining perfusion
pressure (blood pressure), the goal is to preserve normal systemic and organ blood
flow and thus tissue oxygenation especially in the vital organs—the brain, heart, and
adrenal glands. In this regard, when it comes to the brain, medicine is at an even
greater disadvantage. For instance, measuring cerebral blood flow (CBF) is more
complex than continuously measuring systemic blood flow (left ventricular output),
which itself has remained a significant challenge. Assessment of systemic blood flow
becomes even more complicated when shunting through the fetal channels (ductus
arteriosus and foramen ovale) occurs during the first few postnatal days in the pre-
1 term neonate. Unfortunately, it is more complicated to detect clinical evidence of
ischemia in the brain in a timely manner in the neonate. In addition, distinct regions
of the brain have different sensitivity to decreased oxygen delivery. Accordingly,
injury to the normally less well-perfused white matter might occur before other
regions suffer damage. Alterations in normal brain activity and seizures are clear
signs of a pathologic process, but they can be difficult to recognize, especially in the
VLBW neonate; although the use of aEEG might be helpful in this regard. As for
seizures, by the time they are present, irreversible injury may have already occurred.
Most importantly, the clinician faces the formidable task of effectively supporting
and protecting the enormously complex developmental processes that take place in
the brain of the preterm infant during the postnatal transitional period and beyond.
In addition, the understanding of how to manage hemodynamic disturbances that
affect CBF, flow-metabolism coupling, brain function and structure, and ultimately
neurodevelopmental outcome is limited.
The intent of this chapter is to review the information available related to the
definition of systemic hypotension as well as the pathogenesis, diagnosis, and treat-
ment of early cerebral perfusion abnormalities that have been shown to precede intra-
cranial hemorrhage and periventricular white matter injury (PWMI) in the VLBW
infant. Because CBF flow-metabolism coupling and cerebral oxygenation in this
population is complex, the discussion is focused on the first postnatal days, during
which the cardiorespiratory transition from fetal to extrauterine life occurs and most
pathologic processes take place. The discussion focuses on some bedside modalities
potentially useful for identifying changes in CBF and cerebral oxygenation. In addi-
tion, a paradigm is presented for the treatment of the pathologic processes underly-
ing clinically evident brain injury in the VLBW infant based on the most up-to-date
monitoring and clinical evidence. Unfortunately, there is sparse evidence related to
the appropriateness and effectiveness of current approaches to treatment of neonatal
hypotension and cardiovascular compromise. The goal is to provide the practitioner
with guidelines for establishing the diagnosis and treatment of neonatal hypotension.
Finally, although the understanding of both the normal and pathologic processes in
the developing preterm brain is improving, a definitive, safe, and effective clinical
approach remains elusive.
Definition of Hypotension
Hypotension, defined by population-based normative data, is present in up to 50%
of VLBW infants admitted to the neonatal intensive care unit. Hypotension in the
immediate postnatal period has historically been thought to be one of the major
factors contributing to central nervous system injury and poor long-term neuro-
logic outcome, including cerebral palsy in VLBW neonates. Indeed, an association
between hypotension and brain injury and poor neurodevelopmental outcome is
well documented1–9 and forms the basis of therapeutic efforts to normalize blood
pressure. However, causation has not been demonstrated between hypotension and
poor neurodevelopment and thus one cannot infer that long-term neurodevelop-
mental outcomes will improve if hypotension is rigorously avoided.10 Therein lies
the conundrum often faced by the neonatologist: when to treat early cardiovascu-
lar compromise in the VLBW neonate, what medication to use, and how quickly
to normalize blood pressure and CBF. Thus a prospective observational study of
Cerebral Circulation and Hypotension in the Premature Infant 3
more than 1000 infants less than 28 weeks’ gestation showed that early postnatal
hypotension was not associated with poorer outcomes.11 Furthermore retrospective
studies have raised additional concerns by demonstrating an association between
“treated hypotension” and poor neurodevelopmental outcomes.12–15 Of note, the
use of the definition “treated hypotension” in these studies has introduced an addi-
tional bias by implying that, in addition to or independent of hypotension, the
treatment might be a factor contributing to the described association. Although
the implication of the potential negative effects of treatment of hypotension is
plausible and thus needs to be prospectively studied, at present no conclusion
can be drawn, especially because other investigators have reported essentially the
opposite finding.16 Unfortunately, all prior studies were uncontrolled, either ret- 1
rospective or observational in nature, and hypotension was treated. There is only
one randomized controlled trial published to date that had a no-treatment arm.17
Owing to difficulties in obtaining informed consent in a timely fashion or refusal of
enrollment by the attending neonatologist, these trials are not feasible to perform.
Interestingly, a follow-up study15 to a randomized prospective trial18 comparing
the effectiveness of dopamine and epinephrine in increasing blood pressure and
CBF in hypotensive VLBW neonates during the first postnatal day found that neo-
nates who responded to dopamine or epinephrine had long-term neurodevelopment
outcomes comparable to those of age-matched normotensive controls. However,
infants who did not respond to vasopressor-inotrope treatment had worse long-
term outcome. However, as the primary outcome measure of the original study18
was not long-term neurodevelopmental outcome, the follow-up study15 was not
appropriately powered to put this concern to rest.
It is clear that the relationship between a given mean blood pressure and asso-
ciated brain oxygen delivery below which the risk for injury is increased remains
unclear. Moreover, there is no clear evidence that increasing blood pressure to the
normal range will normalize oxygen delivery. Mean arterial pressure (MAP) is
considered by some to be less important than other indirect clinical indicators of
decreased perfusion, such as capillary refill time (CRT), urine output, and lactic aci-
dosis. This approach ignores the physiologic principle that a pressure gradient is
necessary to drive flow (Poiseuille’s law). Simplistically, to provide blood flow to
the brain, the systolic arterial pressure has to be higher than the intracranial pressure.
Obviously, the dependent variables of systemic hemodynamics (cardiac output and
SVR) determine blood pressure and thus tissue oxygen delivery. However, ignoring
MAP itself, as implied by some, may not be prudent and even feasible.17 In summary,
blood pressure should be considered as one of the markers of adequacy of circula-
tory function but not the only or primary marker. Indeed, low blood pressure implies
impairment of vasomotor tone, low cardiac output, or both. Conversely, a normal
blood pressure indicates either normal cardiac output and vasomotor tone or a com-
pensated state, in which either cardiac output is increased to compensate for the low
vasomotor tone or the vasomotor tone is elevated to compensate for the low cardiac
output (Fig. 1.1).19 In older children and adults, vital organs are relatively protected
in the compensated phase of shock. Unfortunately, this may not be the situation in the
preterm infant—hence the limitation of primarily relying on blood pressure monitor-
ing in an effort to assess the adequacy of circulation.
In clinical practice, hypotension is usually defined as the blood pressure value
below the 5th or 10th percentile for the gestational and postnatal age–dependent nor-
mative blood pressure values (Fig. 1.2).20,21 Interestingly, findings of a recent study
suggest that the normative values may actually be low; that is, physiologically normal
blood pressure in VLBW infants may actually be higher than has been commonly
accepted.22 Moreover, owing to the compensatory mechanisms, a certain blood pres-
sure value in a given patient might be associated with normal oxygen delivery at one
point in time while the same value may indicate true hypotension (abnormal tissue
oxygen delivery) at another time.19 Accordingly, there is no consensus among neona-
tologists about the acceptable lower limit of systemic mean or systolic arterial blood
pressure, and most units have different guidelines for the initiation of treatment
of hypotension. From a pathophysiological standpoint, three levels of functional
4 Neurology
+ + + +
55
Mean blood pressure (mm Hg)
37–43 weeks
50
45 33–36 weeks
40
27–32 weeks
35
23–26 weeks
30
25
20
0 12 24 36 48 60 72
Age (hours)
Fig. 1.2 Gestational age‒ and postnatal age‒dependent nomogram for mean blood pressure values in pre-
term and term neonates during the first 3 postnatal days. The nomogram is derived from continuous arterial
blood pressure measurements obtained from 103 neonates with gestational ages between 23 and 43 weeks.
As each line represents the lower limit of 80% confidence interval of mean blood pressure for each gestational
age group, 90% of infants for each gestational age group will have a mean blood pressure equal or greater than
the value indicated by the corresponding line (the lower limit of confidence interval). (From Nuntnarumit P, Yang
W, Bada-Ellzey HS. Blood pressure measurements in the newborn. Clin Perinatol. 1999;26(4):981–996. Used with
permission.)
CBF
(mL/100 g/min)
Autoregulatory Blood pressure at
CBF threshold autoregulatory threshold(?)
Ischemic CBF
Blood pressure at
threshold at 50% of
ischemic threshold(?)
resting CBF
1
MBP (mmHg)
Fig. 1.3 Definition of hypotension by three pathophysiologic phenomena of increasing severity: autoregulatory,
functional, and ischemic thresholds of hypotension. CBF, Cerebral blood flow; MBP, mean blood pressure.
15 15
(µmol/L)
(µmol/L)
HbD
HbD
0 0
–15 –15
0 5 10 15 20 25 30 0 5 10 15 20 25 30
Time (min) Time (min)
50 50
(mm Hg)
(mm Hg)
40
MAP
40
MAP
30 30
20 20
0 5 10 15 20 25 30 0 5 10 15 20 25 30
Time (min) Time (min)
100
100
90
SaO2
90
SaO2
%
%
80 80
70 70
0 5 10 15 20 25 30 0 5 10 15 20 25 30
Time (min) Time (min)
A B
Fig. 1.4 Intact and compromised cerebral blood flow (CBF) autoregulation in very low-birth-weight neonates in
the immediate postnatal period. Changes in cerebral intravascular oxygenation (hemoglobin D [HbD] = oxyhe-
moglobin [HbO2] ‒ hemoglobin [Hb]) correlate with changes in CBF. A, Changes in HbD (i.e., CBF), mean arterial
pressure (MAP), and oxygen saturation (Sao2) in a 1-day-old 28-week gestation preterm infant whose subsequent
head ultrasound findings remained normal. No change occurs in CBF in relation to the sudden increase in MAP
associated with endotracheal tube suctioning (arrow). B, Changes in HbD (CBF), MAP, and Sao2 in a 1-day-old,
27-week‒gestational age preterm infant whose subsequent head ultrasound revealed the presence of periventricu-
lar white matter injury. Changes in blood pressure are clearly associated with changes in CBF. (From Tsuji M, Saul PJ,
duPlessis A, et al. Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature
infants. Pediatrics. 2000;106(4):625–632. Used with permission.)
neonate during the first postnatal day (Fig. 1.5).25,26 However, this is rather arbitrary
as it remains unclear at values around this range whether cellular function and struc-
tural integrity are affected, because increased cerebral fractional oxygen extraction
(CFOE), microvascular vasodilation, and a shift in the hemoglobin-oxygen dissocia-
tion curve to the left can maintain tissue oxygen delivery at levels appropriate to
sustain cellular function and integrity.29,30
If blood pressure continues to fall, it will reach a value at which cerebral func-
tion becomes compromised (functional blood pressure threshold). Data suggest that
the functional blood pressure threshold may be around 22 to 24 mm Hg in the VLBW
neonate during the first postnatal days (Fig. 1.6).31,32 However, caution is needed
1 when interpreting these findings because the data were obtained in a small number
of preterm infants.
Finally, if blood pressure decreases even further, it reaches a value at which
brain tissue structural integrity becomes compromised (ischemic blood pressure
threshold). On the basis of findings in immature animals, it is assumed that the isch-
emic CBF threshold is around 50% of resting CBF.25 Although it is unclear which
blood pressure value represents the ischemic CBF threshold in the VLBW neonate
during the first postnatal day, it may be at or below 20 mm Hg (see Fig. 1.3).31,32 It
is important to emphasize that the situation is further complicated by the fact that
these numbers represent moving targets for the individual patient influenced by his
or her ability to compensate for decreases in blood pressure and oxygen delivery. In
addition, other factors, such as the different sensitivity of brain structures to perfu-
sion changes, arterial partial pressure of carbon dioxide (Paco2) levels, the presence
of acidosis, preexisting insults (interruption of placental blood flow [i.e., asphyxia]),
and underlying pathophysiology (sepsis, anemia), all have an impact on the critical
Pre-Dopamine
Control (no dopamine) Dopamine
40 40
CBF (mL/100 g/min)
29
30 30
20 20
10 10
0 0
20 25 30 35 40 45 50 20 25 30 35 40 45 50
20 45
Residual sum of
Residual sum of
40
squares
squares
35
30
15 25
20 25 30 35 40 45 50 20 25 30 35 40 45 50
C MAP (mm Hg) D MAP (mm Hg)
Fig. 1.5 Relationship between cerebral blood flow (CBF) and mean arterial pressure (MAP) in hypotensive and
normotensive extremely low-birth-weight (ELBW) neonates during the first postnatal day and the effect of dopa-
mine on this relationship. A and B, MAP (mm Hg) and CBF (mL/100 g/min) assessed by near-infrared spectroscopy
in normotensive ELBW neonates not requiring dopamine (Control [solid squares]; n = 5) and hypotensive ELBW
neonates before dopamine administration (pre-dopamine [open circles]; n = 12). The lower threshold of the CBF
autoregulatory blood pressure limit (29 mm Hg; A) is identified as the minimum of the residual sum of squares
of the bilinear regression analysis (B). C and D, MAP (mm Hg) and CBF (mL/100 g/min) in previously hypotensive
ELBW neonates after dopamine treatment (solid circles). No breakpoint is evident in the CBF-MAP curve in ELBW
neonates receiving dopamine (C), because there is no minimum identified by the bilinear regression analysis (D).
(From Munro MJ, Walker AM, Barfield CP. Hypotensive extremely low birth weight infants have reduced cerebral
blood flow. Pediatrics. 2004;114(6):1591–1596. Used with permission.)
Cerebral Circulation and Hypotension in the Premature Infant 7
90
80
60
50
40 1
30
20
10
10 20 30 40 50
MBP (mm Hg)
Fig. 1.6 Relationship between mean blood pressure (MBP) and cerebral electrical activity in very low-birth-weight
neonates during the first 4 postnatal days. The relationship between MBP and the relative power (RP) of the delta
band of the electroencephalogram (EEG) is shown as the line of best fit with 95% confidence interval (n = 35; R2 =
0.627; P < .001). The horizontal dotted lines represent the normal range of the relative power of the delta band (10th–
90th percentile), while the vertical dotted line identifies the point of intercept. The open square identifies the infant with
abnormal cerebral fractional oxygen extraction and the abnormal EEG records are circled. (From Victor S, Marson AG,
Appleton RE, et al. Relationship between blood pressure, cerebral electrical activity, cerebral fractional oxygen extraction
and peripheral blood flow in very low birth weight newborn infants. Pediatr Res. 2006;59(2):314–319. Used with permission.)
blood pressure value at which perfusion pressure and cerebral oxygen delivery can-
not satisfy cellular oxygen demand to sustain autoregulation, then cellular function,
and finally structural integrity.
In most units, continuous monitoring of blood pressure and assessment of indirect
signs of tissue perfusion (urine output, CRT, and lactic acidosis) still form the basis for
identifying the presence of cardiovascular compromise. As discussed earlier, though,
“adequate” blood pressure may not always guarantee adequate organ perfusion in
VLBW neonates, especially during the first postnatal day.33 Indeed, blood pressure only
weakly correlates with superior vena cava (SVC) flow in VLBW neonates during the
period of immediate postnatal adaptation.34 Of note, SVC flow has increasingly been
used in the clinical practice as a surrogate for systemic blood flow in the VLBW neo-
nate during the immediate postnatal period, when shunting through the fetal channels
prohibits the use of left ventricular output to assess systemic blood flow.35 The find-
ing that adequate blood pressure may not always guarantee adequate systemic blood
flow in these patients may be explained, at least in part, by the notion that the cerebral
vascular bed, especially of the 1-day-old ELBW neonate, may not be of high priority
assignment yet and thus it will constrict, as do the vessels do in the nonvital organs,
rather than dilate in response to a decrease in the perfusion pressure (see later text).36,37
of systemic and organ blood flow, especially CBF and brain activity. We review most
of the existing technologies, including echocardiography and Doppler ultrasound,
impedance electrical cardiometry (IEC), NIRS, and aEEG, and discuss the applica-
bility and limitations of these modalities.
A logical place to begin the discussion on monitoring CBF in the VLBW infant
is to ask, “What is normal CBF in the VLBW infant?” Several investigators have
addressed this issue. It is clear from these studies that CBF is lower in preterm
infants than in adults, corresponding to the lower metabolic rate of the preterm
brain. A study using xenon 133 (133Xe) clearance39 found that in 42 preterm infants
with a mean gestational age of 31 weeks, CBF was 15.5 ± 7.2 mL/100 g/min dur-
1 ing the first postnatal week, a value three to four times lower than that in adults.
Interestingly, patients enrolled in this study who were receiving mechanical ventila-
tion had lower CBF than their nonventilated counterparts and those supported by
continuous positive airway pressure (CPAP) (11.8 ± 3.2 vs. 19.8 ± 5.3 and 21.3 ±
12 mL/100 g/min, respectively). CBF in this study was not consistently affected by
postnatal age, gestational age, birth weight, mode of delivery, Paco2, hemoglobin
concentration, mean blood pressure, or phenobarbital therapy. In contrast, subse-
quent publications by the same group of authors investigating CBF reactivity in pre-
term infants during the first three postnatal days showed that, as expected, Paco2 and
hemoglobin concentration significantly affect CBF in this patient population.40–42
However, the relationship between Paco2 and CBF appears to be also affected by
postnatal age during the immediate postnatal period (see later text). Using posi-
tron emission tomography (PET) to measure CBF, a study found43 lower values
for CBF in preterm and term neonates compared with those obtained by the use of
133Xe clearance. More importantly, the authors reported that, in 1 term and 5 preterm
infants with CBF between 4.9 and 10 mL/100 g/min, the term neonate and 3 of the
preterm infants had normal neurodevelopmental outcome at 24 months.43 These
data suggest that the “neurodevelopmentally safe” lower limit of CBF in the neonate
is lower than predicted and may be between 5 and 10 mL/100 g/min. Finally, as
mentioned earlier, because CBF is affected by many factors other than blood pres-
sure, it is not possible to define the blood pressure value consistently associated with
a decrease of CBF below the safe limit that results in ischemic brain injury.
Kluckow and Evans, using SVC flow as a surrogate for CBF, established nor-
mal values of SVC flow during the first 48 postnatal hours in well preterm neonates
younger than 30 weeks’ gestation who were receiving minimal ventilatory sup-
port.35 However, it must be stated that the extent to which SVC flow is representa-
tive of systemic or CBF in preterm neonates during the first postnatal days is not
understood. In a subsequent study that included sick preterm infants younger than
30 weeks’ gestation, the same group found that 38% of infants had a period of low
SVC in the first 24 postnatal hours.33 The incidence of low SVC flow was sig-
nificantly related to the level of immaturity, and more than 70% of low SVC flow
occurred in very preterm neonates (< 27 weeks’ gestation). The sudden increase in
the peripheral vascular resistance caused by the loss of the low-resistance placen-
tal circulation when the cord is clamped immediately after delivery, the complex
process of cardiorespiratory transition to the postnatal circulatory pattern, and myo-
cardial and autonomic central nervous system immaturity have all been proposed to
contribute to these findings. Indeed, these factors may explain why many of these
very preterm neonates struggle to maintain normal systemic blood flow during the
first 12 to 24 postnatal hours. Of note is that using “physiologic” (delayed) rather
than immediate cord clamping, immediate postnatal hemodynamic transition, and
the incidence of associated cerebral pathologies have changed.44,45 Importantly, a
proportion of the very preterm infants with extremely low SVC flow were found to
have systemic blood pressures in the “normal” range (i.e., greater than or equal to
their gestational age in weeks), a finding supported by subsequent studies of this
group of researchers.34,36,37 Because normal blood pressure and decreased organ
blood flow to nonvital organs are the hallmarks of the compensated phase of shock
and because a portion of SVC flow represents blood returning from the brain, a vital
organ, it is conceivable that that the proposed low-priority vessel (nonvital organ)
Cerebral Circulation and Hypotension in the Premature Infant 9
assignment of the vascular beds of the forebrain (cerebral cortex and white matter)
in the very preterm neonate during the immediate postnatal period explain these
findings. This hypothesis, which is supported by studies in different animal mod-
els46,47 and, indirectly, in the human neonate,36,37,48 may explain, at least in part,
why SVC blood flow may be decreased in some very preterm neonates who have
normal systemic blood pressure. Most preterm neonates with documented low SVC
flow in the first 24 to 48 hours who do not go on to have P/IVH or PWMI are more
mature (28 weeks’ and beyond vs. 25–26 weeks’ gestation). Thus for preterm infants
of less than 30 weeks’ gestation, preexisting low systemic blood flow (and CBF)
may be necessary but not sufficient to cause intracranial pathology. Importantly,
all patients studied had an increase in SVC flow by 24 to 36 hours, and all P/IVHs 1
occurred after the SVC flow had increased. Findings of a later prospective obser-
vational study by our group using echocardiography and NIRS confirm and expand
these observations.49 In this study, very preterm neonates who presented with lower
systemic blood flow and higher cerebral vascular resistance during the first 12 post-
natal hours were at a higher risk for the development of P/IVH. Importantly, the
bleeding occurred only after cardiac output and brain blood flow had increased. In
addition, lower cerebral tissue oxygenation levels detected by NIRS during the first
12 postnatal hours might identify the patients who will subsequently develop P/
IVH.49 Taken together, these findings implicate an ischemia-reperfusion cycle in the
pathogenesis of P/IVH in very preterm neonates during the immediate transitional
period.
It is important to note that the methods used to assess systemic and CBF in
VLBW neonates in the immediate transitional period have significant limitations.
When SVC flow is used to assess systemic and CBF, the measurements are operator
dependent owing to the uncertainties associated with the accurate measurement of
vessel diameter and flow velocity. The fluctuations in vessel size during the cardiac
cycle and the flow velocity pattern in the SVC are important factors contributing to
these technical difficulties. In addition, the shape of the SVC, the lack of data on the
magnitude of the contribution of CBF to SVC flow in the human neonate, and the
lack of a documented association between Paco2 and SVC flow in this patient popu-
lation call for caution in the interpretation of these findings.
Yet an association has been found between SVC flow and aEEG indices of oxy-
gen utilization (continuity and amplitude) in the first 48 postnatal hours.50 A finding
of this study also demonstrated that hypotension, either treated or untreated, was
associated with decreased levels of brain activity as assessed by aEEG.50 This find-
ing supports the previously referenced data18,23,29 indicating that blood pressure and
brain oxygen utilization are inextricably linked.
In another study, CBF was measured in both the internal carotid and vertebral
arteries and the sum of the flow in the four arteries supplying the brain was used
to assess the changes in CBF volume in preterm infants of 28 to 35 weeks’ gesta-
tion over the first 2 postnatal weeks.51 Although the technique, again, has signifi-
cant limitations, the findings suggest that a steep rise in CBF occurs from the first
to the second postnatal day and that this pattern is independent of gestational age.
Thereafter CBF continues to rise gradually (Fig. 1.7). Because brain weight does not
significantly increase during the first 48 postnatal hours, the investigators inferred
that the observed increase in CBF during that period was secondary to increased
cerebral perfusion per unit weight of tissue. On the other hand, the more gradual
increase over the ensuing 2 weeks is likely due to a combination of both increased
brain weight and increased perfusion.51 This study enrolled only healthy preterm
infants with normal brains, whereas investigations in other studies33,34,52,53 included
a group of preterm infants who were sicker and had a higher incidence of significant
intracranial pathology. Nevertheless, the results in the two groups of patients are
complementary as they provide evidence for a decreased CBF in the first postnatal
day, followed by a significant increase by the second postnatal day. Although low
CBF in the first postnatal day and the ensuing “reperfusion” appears to be a physi-
ologic phenomenon likely occurring in all very preterm neonates, CBF is even lower
in those who later develop P/IVH.49 Therefore the phenomenon of low CBF is also a
Another random document with
no related content on Scribd:
to the danger to a certain extent. I swear, however, that not all the
gold in the world would induce me to do again what we did on this
trip under similar conditions. Ten times a day at least we had to face
these awful rapids, to go through all the agony of suspense,
succeeded by the awful sensation of passing over the obstacles
before us, whilst the boat seemed to rush from beneath us and
plunge into the foam, from which it seemed simply impossible that
she should ever again emerge.
Or again some rock barred our passage, and only by force of
moving were we able to make our way inch by inch against the
current which threatened to sweep us away. Then, as we literally
scraped the rock, we knew that two or three inches made all the
difference between life and death! For there would have been no
hope of escape if we were once upset in these awful rapids. Death
would have been inevitable, for the best swimmer could not have
made head against such currents as these, but would have been
dashed to pieces by them against the rocks.
Or supposing that by a miracle he should escape death by
drowning or by being flung upon the rocks, a yet more awful danger
awaited him after he had safely passed the rapids, for beneath all of
them many terrible crocodiles lie concealed, on the watch for the
luckless fish, which, rendered giddy by the whirling turmoil of water,
simply swim into their jaws. Crocodiles, you must know, do not kill
their prey as sharks do, and no death could be more terrible than
that inflicted by these awful denizens of the Niger, for they plunge
their victims under water and drown them. Imagine what it must be to
feel oneself gripped by the huge teeth of a merciless brute and
dragged along until death from suffocation ensues.
THE ‘AUBE’ IN THE LAST LABEZENGA RAPID.
General Skobeleff said one day, “If any one says to you that he
has never been afraid, spit in his face and tell him he is a liar!”
I don’t in the least mind owning that we were afraid, that we knew
what fear was day by day for a whole month; fear in the day at the
passage of every fresh obstacle, and yet greater fear in the night, for
then nightmare exaggerated the horrors of the light, crocodiles and
rapids haunting our sleep in dreams more awful even than the reality
had been.
I challenge in advance the next person who goes down the Niger
to say whether I have exaggerated anything in this account.
LOOKING UP STREAM FROM KATUGU.
We had to push on, however, and the first thing to be done was to
replace the burnous of Mamé, which still served as a plug in the hole
in the Davoust, with something a little more suitable for the purpose.
We had brought with us a piece of aluminium to meet just such an
emergency as this, but we had neither the time nor the means to
rivet it now. So we cut a piece of wood the right size to serve
provisionally, and fitted it into the hole, interposing a kind of mattress
of tarred oakum, and making the whole thing taut with the aid of two
strong bolts. Some putty made it more or less watertight, and
anyhow we could now keep our Davoust afloat.
The next day, the 16th, was as exciting as the 15th had been.
Three very strong rapids succeeded each other, completing the
awful pass of Labezenga. At each one the barges were halted above
the fall, and a reconnaissance was made, then they passed over one
by one, with the crew strengthened by every man who could be
pressed into the service. Digui continued to show wonderful
intrepidity, a quiet audacity and courage, and a readiness to grasp
the bearings of every situation, which were beyond all praise. We
can really say without exaggeration that we owed not only the safety
of our boats, but our very lives to him.
AT SANSAN-HAUSSA.
We went with Father Hacquart to return the visit the chief of the
village had paid us the evening before. He did not seem to wish us to
remain long in his country. He was afraid, he said. Why? we asked. It
was evident that the Toucouleurs, of whom there were a good many
in the village, had prejudiced him against us.
Two people came and asked us to give them a passage, one a
Fulah named Mamadu of Mumi in Massina, who had been here for
nine years unable to get away. We were to have a good deal to do
with him during our stay at Say.
The other was a Toucouleur named Suleyman, who spoke Wolof,
and had followed Amadu Cheiku in his exodus from Nioro to Dunga.
He was a poor deaf old man, but had a very intelligent face. He told
us that the whole recompense Amadu had given him for his long and
faithful service was to take away his gun, his only wealth, to give it to
one of his sofas or captives taken in war. This last misfortune had
disgusted Suleyman with the Holy War, in which he said more blows
than pay were received, and he wanted to go back with us to his own
land of Footah on the Senegal, the reigning chief of which was a
relation of his.
He did not know what we had come here for. He did not know
what route we meant to take on our way back, and surely nothing
could have been a greater mark of confidence in us than this
readiness of one of our worst enemies to trust himself to us.
At first I rather distrusted the man, who might be a spy, or worse,
a traitor sent to try and seduce my men from their duty. However,
whilst resolving to watch him closely, I decided to take him with us,
but I gave him a good talking to to begin with, saying—“I don’t know
whether you are a liar or an honest fellow, but most of your relations
are deceivers and humbugs, and it is no recommendation in my eyes
that you belong to the Toucouleur race. However, I will not be unjust,
for I may be mistaken about you. So you can come with us, and you
will be treated as if you were one of my own men. If we have plenty
you shall have your share, and if we run short of food you will have
to tighten your waistband like the rest of us. But deceive us once,
only once, and your head will not remain on your shoulders for a
moment. You are warned, please yourself about going or stopping.”
I must add here that Suleyman, the Toucouleur, or, as he was at
once called amongst us, Suleyman Foutanké, was always true to us.
I took him with me to Saint Louis, and he is now enjoying in his natal
village a repose which must indeed be grateful to him after his thirty
years’ wanderings.
We started again at two o’clock in the afternoon, and in the
evening we halted for the night not far from Sorbo, where we were to
see the chief of the Kurteyes.
We went to see him the next day, and passed the morning at
Sorba. We were very well received by Yusuf Osman. Don’t tell him
that I have revealed his name to the public, for amongst the Kurteyes
it is very bad form to call any one by his name. I have noticed that
there is a similar superstition in the Bambara districts of the Upper
Niger.
Yusuf is a big, good-looking fellow of about forty years of age,
who has recently succeeded his father as chief. When we arrived he
was suffering from some affection of the eyes. Taburet prescribed for
and cured him, thus contributing to establishing us in his good
graces.
The former chief of Sorba had been a great friend of Amadu, and
had given him canoes for crossing the river. If therefore the
Toucouleurs had succeeded in establishing their authority in the
districts torn from the Djermas of Karma and Dunga, it was in some
measure due to him.
Yusuf, however, did not disguise that he was becoming rather
uneasy about the future, and as far as was possible without
compromising himself he had tried to be useful to us. If ever we
succeed, as I hope we shall, in driving Amadu from the
neighbourhood of Say, we shall certainly find auxiliaries in the
Kurteyes.
Yusuf gave us as a guide to take us to Say, a man named Hugo,
chief of his own slaves, a capital fellow, and an excellent pilot.
Needless to add that we all at once dubbed him Victor in honour of
the great French author.
Relieved on the point about which I had been so anxious, the
securing of a guide to take us to Say, we went down to the village of
Kutukole, and anchored near it for the night, the river between it and
Sarbo being quite easy to navigate.
On the 3rd we passed Karma, and were now amongst the
Toucouleurs. On every side our approach was announced by the
lighting of fires, and the beating of the tabala or war-drum. A group of
horsemen followed us along the bank, watching us closely, but now
the stream was quite quiet, only one more rapid, that of Bobo, had to
be crossed, and that we left behind us the same evening. All we had
to do was to steer carefully clear of the few rocks which still impeded
the course of the river.
Bobo, opposite to which we passed the night, is, like Karma,
under the direct authority of Ali Buri, that venerable Wolof chieftain,
who, driven out of Cayor by the French, went to seek an asylum at
Nioro near Amadu, whose fortunes he followed. Captain Toutée was
mistaken in thinking that Ali Buri had been killed in the attack on his
expedition at Kompa. He was still alive, unfortunately for us, and we
were told was now in the Sorgoé district near the country of the Kel
Gheres, where he busied himself in winning partisans for Amadu.
On the right bank opposite our anchorage, Bokar Wandieïdu had
fought the year before with the Futankes, and had inflicted on them a
serious defeat. More than two hundred of Amadu’s warriors are still
prisoners in the hands of the Tuareg chief. Unfortunately, however,
after the Sinder affair, the chief of Say succeeded in reconciling the
enemies, and, as we have seen, the truce between them was
brought about at the expense of the French.
The 5th of April was Easter Sunday, and Father Hacquart
celebrated mass as we slipped easily down stream through
charming scenery, preceded by Hugo in his canoe acting as guide.
We passed several big villages belonging to the chiefs under
Amadu, and anchored opposite Saga.